Johns Hopkins Singapore International Medical Centre

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Johns Hopkins Singapore (JHS), a joint venture between the National Healthcare Group (NHG) and Johns Hopkins Medicine International (JHMI), operates an inpatient and outpatient oncology program for both private and public patients in collaboration with Tan Tock Seng Hospital (TTSH). JHS specializes in advanced treatments for a wide range of adult cancers and provides medical screenings and health check-up services.

Established in 2000 as The Johns Hopkins Hospital’s outpost in Southeast Asia, JHS strives to extend the Johns Hopkins tradition of excellence in research, education and patient care across Asia Pacific. In 2004, JHS became Singapore's first private hospital to be accredited by the Joint Commission International, the world leader in health care standards.

Through medical education and research, including collaborations with the Johns Hopkins University School of Medicine, the National University of Singapore and the National University Hospital, JHS strives to develop cutting-edge therapies and technologies to provide patients with a better quality of life during and after treatment.

Now celebrating 15 years in Asia, JHS is committed to providing patients and their family members with the highest quality of care.

More on Patient Care[edit]

  • Johns Hopkins Singapore provides innovative, world-class cancer care in a comfortable, healing setting.
  • JHS researchers and clinicians work closely with colleagues in the United States to ensure the latest therapies are transferred quickly from the lab to your care. JHS also has access to the latest findings from Johns Hopkins Medicine.
  • Cancer is complex, and research and care advancements are fast-moving. Connecting research and education to patient care—the hallmark of academic medicine—means that patients have access to care based on the most recent knowledge.
  • Research shows that care improves when systems are designed around patients and their families, and treatment is individualized.

Dedicated professionals strive to offer the highest quality of personalized health care. JHS specializes in advanced treatments for a wide range of adult cancers which include:

  • Lung
  • Breast
  • Ovarian
  • Uterine
  • Cervical
  • Head and Neck
  • Nasopharynx
  • Thyroid
  • Stomach
  • Liver
  • Colon
  • Lymphoma
  • Prostate
  • Bladder
  • Kidney
  • Brain

JHS also provides a full range of consultations and treatments for general medical conditions.

More on Research[edit]

  • The hallmark of an academic medical center is translational research—not only making new discoveries but also applying and sharing these findings around the world to advance health and health care.
  • Researchers at Johns Hopkins Singapore and Johns Hopkins Medicine have collaborated for more than a decade to better understand cancers common to Southeast Asia, including liver and nasopharyngeal.
  • This multidisciplinary collaboration helps develop more effective, specialized treatments and improve care in ways that best fit local needs.
  • Research helps detect cancer earlier and develop less invasive therapies, which can provide JHS patients with a better quality of life during and after treatment.
  • JHS researchers participate in studies to develop new drugs at the international level—helping patients gain early access to new medication.
  • JHS scientists attract grants and bring research funding into Singapore.
  • For four years now, Johns Hopkins Singapore has partnered with Tan Tock Seng Hospital to host a joint oncology symposium for clinicians. Johns Hopkins oncologists participate to share the latest cancer research and advance global health care.
  • For more information on JHS’s current and on-going clinical trials, please click here.

More on Education[edit]

  • Academic medical centers like Johns Hopkins are uniquely positioned to help share knowledge globally and develop flexible, sustainable solutions tailored to each region.
  • Education puts Johns Hopkins Singapore at the forefront of medical advancements—driving JHS to continuously enhance their practice and patient care, reinvent their capabilities and address the complexity of today’s health care.
  • Since 2004, Johns Hopkins Singapore has been a qualified site for medical students and resident rotations from The Johns Hopkins University, Mexico, Taiwan and local universities.
  • Johns Hopkins Singapore physicians have academic appointments at The Johns Hopkins University's School of Medicine. The majority have been trained at the Accreditation Council for Graduate Medical Education and accredited by U.S. training programs in internal medicine and medical oncology.
  • Johns Hopkins Singapore collaborates with Tan Tock Seng Hospital in sharing Johns Hopkins Medicine expertise and educating Lee Kong Chian School of Medicine students.
  • As the assistant director of clinical education at Johns Hopkins Singapore and a core faculty member of the National Healthcare Group Senior Residency Program, JHS Medical Director Lavina Bharwani has been heavily involved in the development of the educational programs offered at Johns Hopkins Singapore. She also helped develop the oncology training programs at Tan Tock Seng Hospital's medical oncology department and is the lead for medical oncology at the Lee Kong Chian School of Medicine in Singapore.